Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein A-I induced amyloidosis

J Genschel1, R Haas, M J Pröpsting

  • 1Abteilung Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover, Germany.

FEBS Letters
|August 4, 1998
PubMed
Summary

Mutant apolipoprotein A-I (apoA-I) forms N-terminal fragments leading to amyloidosis. Understanding apoA-I metabolism and structure may reveal common mechanisms for this organ-damaging disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeated deep-inspiration breath-hold CT scans at planning underestimate the actual motion between breath-holds at treatment for lung cancer and lymphoma patients.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2023
Same author

Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.

ESMO open·2023
Same author

Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased?

United European gastroenterology journal·2018
Same author

Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT.

Acta oncologica (Stockholm, Sweden)·2017
Same author

Hepatobiliary and Pancreatic: Fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma.

Journal of gastroenterology and hepatology·2017
Same author

The C/C_₁₃₉₁₀ and G/G_₂₂₀₁₈ Genotypes for Adult-type Hypolactasia are not Associated with Inflammatory Bowel Disease.

Scandinavian journal of gastroenterology·2017

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medical Science

Background:

  • Amyloidosis involves extracellular protein fibril deposits, primarily beta-sheets, causing organ damage.
  • Apolipoprotein A-I (apoA-I) is crucial for lipid metabolism and high-density lipoprotein (HDL) regulation.
  • Typically, apoA-I is not linked to amyloidosis, but four mutant forms are known.

Purpose of the Study:

  • To summarize features of known amyloidogenic apoA-I variants.
  • To explore the metabolic pathway of apoA-I in amyloidosis.
  • To hypothesize common mechanisms for apoA-I-induced amyloidosis.

Main Methods:

  • Review and summarization of existing data on apoA-I variants and amyloidosis.
  • Analysis of N-terminal fragment formation in amyloid deposits (residues 1-83 to 1-94).
  • Speculation on the metabolic pathway and structural findings related to apoA-I amyloidogenesis.

Main Results:

  • Four naturally occurring mutant forms of apoA-I are associated with amyloidosis.
  • A key feature is the consistent formation of N-terminal fragments (residues 1-83 to 1-94) in amyloid deposits.
  • New insights into apoA-I's association with HDL and its metabolism are presented.

Conclusions:

  • Understanding apoA-I's role in HDL metabolism and its structural properties may explain apoA-I-induced amyloidosis.
  • The identified fragments and metabolic pathways offer potential targets for understanding and treating this condition.
  • Findings may have broader implications for apoA-I metabolism research.

Related Experiment Videos